Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) Times Interest Earned (2021 - 2025)

Kezar Life Sciences' Times Interest Earned history spans 5 years, with the latest figure at -$48.34 for Q2 2025.

  • For Q2 2025, Times Interest Earned rose 17.1% year-over-year to -$48.34; the TTM value through Sep 2025 reached -$63.11, up 2.38%, while the annual FY2024 figure was -$56.88, 20.88% up from the prior year.
  • Times Interest Earned for Q2 2025 was -$48.34 at Kezar Life Sciences, up from -$50.8 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$48.34 in Q2 2025 and bottomed at -$88.7 in Q4 2021.
  • The 5-year median for Times Interest Earned is -$60.01 (2022), against an average of -$62.89.
  • The largest annual shift saw Times Interest Earned crashed 51.02% in 2023 before it surged 36.06% in 2024.
  • A 5-year view of Times Interest Earned shows it stood at -$88.7 in 2021, then soared by 35.28% to -$57.4 in 2022, then plummeted by 51.02% to -$86.69 in 2023, then soared by 36.06% to -$55.43 in 2024, then increased by 12.79% to -$48.34 in 2025.
  • Per Business Quant, the three most recent readings for KZR's Times Interest Earned are -$48.34 (Q2 2025), -$50.8 (Q1 2025), and -$55.43 (Q4 2024).